We can’t solve all the world’s problems at once. But with your help, Southern Research can continue to make groundbreaking discoveries in a number of pivotal fields. Our annual Change Campaign raises money for three critical research areas at SR: cancer research, environmental science, and neuroscience. And with you alongside us, we can turn those groundbreaking discoveries into life-changing advancements for all humankind.




Since our cancer research began in 1946, SR’s scientists have saved countless lives by developing critical cancer-fighting chemotherapy techniques, discovering seven FDA approved anticancer drugs, and evaluating half of all cancer drugs currently on the market. Our researchers continue to build on this rich legacy, exploring promising methods to attack cancer through new treatment targets, ways to activate the immune system to kill tumor cells, and a pipeline of potentially life-changing new cancer drugs. By supporting the Change Campaign, you can help bring us closer to innovative therapies to combat colorectal, pancreatic, and brain cancer — among so many others — all while providing hope to families affected by this devastating disease.




Imagine plentiful, easy access to clean energy from sustainable sources. Imagine renewable, environmentally responsible alternatives to petroleum-derived chemicals. Our scientists are working to turn that imagination into reality. SR is working to preserve the environment and our quality of life, finding new, better ways to clean our water, store energy efficiently, and safely turn substances like carbon dioxide, coal, and waste biomass into the materials of our daily lives. Your donation to the Change Campaign will support these critical advances that will benefit all of humanity and make our planet a cleaner, greener, healthier place to live.



Neurodegenerative diseases and disorders like ALS, Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, schizophrenia, and depression are affecting more and more people — and yet treatment options remain largely unknown. Many of us know someone with an age-related neurodegenerative disorder, and while we can see the disease affecting a person’s personality and ability to perform everyday tasks, it can be hard to understand what’s happening and why. Funding is crucial to keep making critical, significant discoveries in neuroscience. Your support of the Change Campaign will allow our team of neuroscientists to expand their research and move potential treatments for these heartbreaking diseases and disorders closer to the patients who need them.




Here’s what we were able to accomplish thanks to the generous donors that gave to the 2018 Change Campaign.


Our team of scientist in the Oncology Department were able to:

-Develop new therapies that enable the body’s immune system to participate in the fight against breast cancer.
-Test our first-in-class therapeutic models of pancreatic cancer.
-Investigate novel compounds in colon cancer


Our team of environmental researchers were able to:

-Develop new chemistries designed to reduce harmful CO2 emissions.
-Scale up research to convert biomass sugars into the building block of carbon fiber.


Our team of neuroscience experts were able to:

-Collect data to leverage funding from the Michael J. Fox Foundation which will allow us to identify neuronal cell death in the brain of people with Parkinson’s Disease.
-Begin new experiments to determine how cell energy impairment occurs in Huntington’s Disease.
-Discover more indispensable data to understand cell death in ALS.
-Study whether a set of compounds can reverse behavioral deficits in psychiatric diseases like depression and schizophrenia.




Turner Burton (Hoar Construction) | James Childs (Maynard, Cooper & Gale) | Key Foster (McWane Inc.) | Raymond Harbert Jr. (Harbert Management Co.) | Rosa Hooper (Medical Properties Trust) | Blair King (Alabama Power) | Robert Maddox (Bradley Arant Boult Cummings LLP) | Virginia Markstein (Arc Realty) | Chris McCauley (Markstein) | Shon Thurman (Wells Fargo)



Marcus Chatterton (Balch & Bingham LLP) | Will Wright (Protective Life) | Miller Girvin (Alabama Capital Network) | Natalie Kelly (Brasfield & Gorrie LLC) | Beeland Nielsen (Coca-Cola Bottling Co.) | Elizabeth Scribner (Regions Bank) | Michael Stone (Porter, White & Co.) | Jonathan Geisen (Baker, Donelson, Bearman, Caldwell & Berkowitz)


Bart Crawford (The Title Group) | William Culpepper (Chester’s International) | Lynn Darty (Milo’s Tea Company Inc.) | John Fallis (Drummond Co.) | Taylor Peake (Motion Mobs) | David Perry (Protective Life) | David Powell (LogicMonitor) | Mitesh Shah (Maynard, Cooper & Gale) | India Vincent (Burr & Forman LLP) | Jon Vogel (Wealth Designs LLC)